Accenture Named a Leader in Everest Group’s Veeva PEAK Services Matrix Assessment 2021

Accenture (NYSE: ACN) has been named a leader in Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210503005172/en/

Everest Group’s Veeva Services PEAK Matrix Assessment 2021 (Graphic: Business Wire)

Veeva helps life sciences enterprises manage customer databases, track drug development, and organize clinical trials. Everest Group assessed how 15 life sciences information technology (IT) providers’ use Veeva and named Accenture a leader for its market impact, vision, and capabilities.

“During the pandemic, the cloud has been invaluable to unlock data and improve collaboration across the ecosystem in the race to develop and get a vaccine to the world,” said Rob Saiter, managing director, Accenture Life Sciences. “The cloud is foundational to the digital transformation that will help speed treatment development and create more meaningful engagement with sites and patients to improve patient outcomes. Earning a leadership position in the Veeva PEAK Services Matrix Assessment is a testament to our teams’ expertise and successful partnering with our clients.”

The Everest Group Veeva PEAK Services Matrix® Assessment analyzed IT service providers' Veeva services capabilities, including market trends for Veeva service and enterprise sourcing considerations highlighting the strengths and limitations of each service provider. Everest noted that Accenture has a strong focus on talent and has also invested in building accelerators, solutions, and frameworks to expedite time-to-market for their clients.

“Accenture’s expertise in guiding strategy for cloud capabilities and demonstrated ability to carry out large-scale transformational engagement covering Veeva’s large portfolio of offerings have earned Accenture its leadership position,” said Chunky Satija, practice director at Everest Group. “This is essential given an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, and it’s quite clear the industry is increasingly switching to cloud-based technologies.”

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 537,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005172/en/